8 April 2023
RNZ's Kim Hill speaks to a participant in our CAR T-cell clinical trial, poet Michele Leggott.
Michele Leggott's latest book of poetry, Face to the Sky, explores her encounter with 19th-century New Zealand botanical artist Emily Cumming Harris.
But there's more to this story - Michele was battling non-Hodgkin's lymphoma while working on the book.
In early 2020, Michele received her diagnosis, just as the Covid-19 lockdowns began. Chemotherapy, radiotherapy, and a stem cell transplant in 2021 failed to cure her cancer. Finally, in early 2022, Michele was able to participate in a CAR T-cell therapy trial at the Malaghan Institute in Wellington.
"This is the future ... The Malaghan trial, the goal of that is to get publicly funded CAR T in this country so that you don't have to be on a trial to get it. If that can happen, it'll bring down hospital costs, you'll save lives."
Related articles
Breakthrough Malaghan and University of Auckland cancer research advances into new biotech venture
16 June 2026
HRC funding to improve CAR T-cell ‘fitness’ and better fight cancer
11 June 2026
What's next for CAR T-cell therapy
27 May 2026
One dollar a day
27 May 2026
Researchers explore 'RENTAL CAR' approach to CAR T-cell therapy
21 May 2026
Ground-breaking CAR-T clinical trial hits midway milestone
15 April 2026